NexturnBioscience Co. Ltd (089140) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.019x

Based on the latest financial reports, NexturnBioscience Co. Ltd (089140) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.51 Billion ≈ $3.06 Million USD) by net assets (₩240.26 Billion ≈ $162.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

NexturnBioscience Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how NexturnBioscience Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read NexturnBioscience Co. Ltd total liabilities for a breakdown of total debt and financial obligations.

NexturnBioscience Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NexturnBioscience Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Citius Pharmaceuticals Inc NASDAQ:CTXR	-0.127x
IVP Limited NSE:IVP	0.067x
Imexhs Ltd AU:IME	-0.103x
Daesang Corp Preference Shares KO:001685	-0.021x
Thai Capital Corporation Public Company Limited BK:TCC	0.110x
Floyd Public Company Limited BK:FLOYD	0.092x
Australian Agricultural Projects Ltd AU:AAP	-0.052x
Opus One Resources Inc V:OOR	0.000x

Annual Cash Flow Conversion Efficiency for NexturnBioscience Co. Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of NexturnBioscience Co. Ltd from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see NexturnBioscience Co. Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩136.62 Billion ≈ $92.59 Million	₩-1.14 Billion ≈ $-774.60K	-0.008x	+41.40%
2023-12-31	₩138.01 Billion ≈ $93.53 Million	₩-1.97 Billion ≈ $-1.34 Million	-0.014x	-29.82%
2022-12-31	₩108.27 Billion ≈ $73.38 Million	₩-1.19 Billion ≈ $-806.98K	-0.011x	-127.83%
2021-12-31	₩92.73 Billion ≈ $62.85 Million	₩3.66 Billion ≈ $2.48 Million	0.040x	+1520.67%
2020-12-31	₩96.77 Billion ≈ $65.58 Million	₩235.94 Million ≈ $159.89K	0.002x	-91.07%
2019-12-31	₩100.16 Billion ≈ $67.88 Million	₩2.74 Billion ≈ $1.85 Million	0.027x	-72.91%
2018-12-31	₩95.51 Billion ≈ $64.73 Million	₩9.63 Billion ≈ $6.52 Million	0.101x	+81.94%
2017-12-31	₩91.77 Billion ≈ $62.19 Million	₩5.08 Billion ≈ $3.45 Million	0.055x	-72.15%
2016-12-31	₩89.89 Billion ≈ $60.92 Million	₩17.88 Billion ≈ $12.12 Million	0.199x	+211.78%
2015-12-31	₩30.04 Billion ≈ $20.36 Million	₩1.92 Billion ≈ $1.30 Million	0.064x	-71.37%
2014-12-31	₩29.08 Billion ≈ $19.70 Million	₩6.48 Billion ≈ $4.39 Million	0.223x	--

About NexturnBioscience Co. Ltd

KQ:089140 Korea Machinery, Tools, Heavy Vehicles, Trains & Ships

Market Cap

$15.66 Million

₩23.11 Billion KRW

Market Cap Rank

#25728 Global

#1924 in Korea

Share Price

₩2215.00

Change (1 day)

-0.89%

52-Week Range

₩2060.00 - ₩3170.00

All Time High

₩56500.00